Latest news
Loading news…
Merck
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Rahway, New Jersey, United States Founded 1891 10001+ employees For Profit
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Merck on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$5.58M
Funding Rounds
2
Last Funding
Acquisitions
38
Monthly Visits
Contacts
0
Ticker
MRK
NYSE - New York Stock Exchange
Patents
3,658
2,030 trademarks
About Merck
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- MRK
- Exchange
- NYSE - New York Stock Exchange
- IPO date
- Dec 19, 1980
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 131
- Mobile apps
- 96
- Downloads (30d)
- 328,254
- Active products
- 61
- Patents granted
- 3,658
- Trademarks
- 2,030
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $1.41B
Company Info
- Founded
- 1891
- Employees
- 10001+
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- Sub-organizations
- 14
- News articles
- 6,568
- Events
- 7
- HQ
- Rahway, New Jersey, United States
- Region
- Greater New York Area, East Coast, Northeastern US
- Exit date
- Dec 19, 1980
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- 5.7
- Trend (90d)
- 3.7
- Last leadership hire
- Apr 30, 2026
- Last layoff mention
- Jun 2, 2026
Merck Funding Rounds
2 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Investor Names | Funding Stage | Org Industries | Org Hq City | Org Hq Country | Org Description | Org Number Of Employees | Org Website | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1–2 of 2Show
Page 1 / 1
Merck Acquisitions
43 results
| Acquiree Name | Acquirer Name | Acquisition Type | Acquisition Terms | Acquiree Industries | Acquiree Hq City | Acquiree Hq Country | Acquiree Description | Acquiree Number Of Employees | Acquirer Industries | Acquirer Hq Country | Acquirer Number Of Employees | Acquirer Ipo Status | Acquiree Website | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals | $6.7B | 2026-03-24 | Merck | Acquisition | Cash | BiotechnologyHealth CareMedicalMedical DevicePharmaceutical | Foster City | United States | Terns Pharmaceuticals develops small-molecule therapies for … | — | — | BiotechnologyHealth CareMedicalPharmaceutical | United States | 10001+ | Public | 38 | www.ternspharma.com | |
| Cidara Therapeutics | $9.19B | 2025-11-14 | Merck | Acquisition | Cash | BiotechnologyHealth CareTherapeutics | San Diego | United States | Cidara Therapeutics develops targeted immunotherapies aimed … | — | — | BiotechnologyHealth CareMedicalPharmaceutical | United States | 10001+ | Public | 38 | cidara.com | |
| Verona Pharma | $10B | 2025-07-09 | Merck | Acquisition | — | BiotechnologyPharmaceuticalTherapeutics | London | United Kingdom | Verona Pharma is a biotechnology company dedicated to discov… | — | — | BiotechnologyHealth CareMedicalPharmaceutical | United States | 10001+ | Public | 38 | www.veronapharma.com | |
| Verona Pharma | $10B | 2025-01-01 | Merck | acquisition | — | BiotechnologyPharmaceuticalTherapeutics | London | United Kingdom | Verona Pharma is a biotechnology company dedicated to discov… | — | — | BiotechnologyHealth CareMedicalPharmaceutical | United States | 10001+ | Public | 38 | www.veronapharma.com | |
| Modifi Bio | $1.3B | 2024-10-23 | Merck | Acquisition | — | BiotechnologyLife ScienceMedicalTherapeutics | New Haven | United States | Modifi Biosciences is a direct DNA modification developing n… | — | — | BiotechnologyHealth CareMedicalPharmaceutical | United States | 10001+ | Public | 38 | modifibio.com |
1–5 of 43Show
Page 1 / 9
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Merck
Loading news…
FAQs about Merck
People who checked this page also checked these
Sectors Merck invests & acquires in
Browse the full Acquirezy directory.